Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
Holding QNCX?
Track your performance easily

Quince Therapeutics (QNCX) Income Statement

503 Followers

Quince Therapeutics Income Statement

Last quarter (Q2 2024), Quince Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Quince Therapeutics's net income was $-27.73M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 52.05M$ 34.62M$ -51.19M$ 90.32M$ 78.89M$ 39.17M
Operating Income
$ -52.05M$ -34.62M$ -51.19M$ -90.32M$ -78.89M$ -39.17M
Net Non Operating Interest Income Expense
$ 3.21M$ 3.48M$ 1.07M$ 620.00K$ 2.04M$ 2.19M
Other Income Expense
$ 6.56M$ 6.00M$ 1.82M$ 247.00K--
Pretax Income
$ -50.60M$ -28.09M$ -51.94M$ -89.94M$ -76.85M$ -36.98M
Tax Provision
$ -181.00K$ -258.00K$ 284.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -56.02M$ -59.61M$ -51.66M$ -89.94M$ -76.85M$ -36.98M
Basic EPS
$ -1.38$ -0.84$ -1.54$ -3.03$ -2.63$ -1.94
Diluted EPS
$ -1.38$ -0.84$ -1.54$ -3.03$ -2.63$ -1.94
Basic Average Shares
$ 157.88M$ 37.24M$ 33.50M$ 29.72M$ 29.18M$ 19.03M
Diluted Average Shares
$ 157.88M$ 37.24M$ 33.50M$ 29.72M$ 29.18M$ 19.03M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 52.05M$ 34.62M$ 52.02M$ 90.32M$ 78.89M$ 39.17M
Net Income From Continuing And Discontinued Operation
$ -56.02M$ -31.39M$ -51.66M$ -89.94M$ -76.85M$ -36.98M
Normalized Income
$ -19.34M-$ 3.11M-$ -76.85M$ -36.98M
Interest Expense
----$ 0.00$ 0.00
EBIT
$ -53.27M$ -28.35M$ -51.94M$ -89.94M$ -78.89M$ -36.98M
EBITDA
$ -53.16M$ -28.02M$ -51.74M$ -89.60M$ -78.56M$ -36.79M
Currency in USD

Quince Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis